Amelioration of Experimental Autoimmune Encephalomyelitis by Anatabine

Daniel Paris(Roskamp Institute), Michael Mullan(Roskamp Institute)

PLoS ONE

January 30, 2013

10.1371/journal.pone.0055392

Cited by 41

Related Papers

Reduction of β-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease

|Journal of Neuroinflammation|2010|165

Distinct Signaling Pathways Regulate TREM2 Phagocytic and NFκB Antagonistic Activities

|Frontiers in Cellular Neuroscience|2019|111

Chronic Anatabine Treatment Reduces Alzheimer’s Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD

|PLoS ONE|2015|35